Clinical Trials Browser

Breast Neoplasms, Neoplastic Cells, Circulating

NCT07398170 2026-02-09

BIOLIMEN-1

Phase NA Not yet recruiting

15 enrolled

CNS

Meningioma, Neoplastic Cells, Circulating, Neoplasm Recurrence, Local

NCT02072616 2026-02-06

CTC-Pancreas

Phase NA Completed

101 enrolled

Neoplastic Cells, Circulating

NCT05360290 2026-02-03

CTCNeoBC-E

Phase NA Recruiting

484 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT05988970 2026-01-27

SLEEP_CTC

Phase NA Completed

27 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT05560776 2026-01-26

OPTIMAL

Phase NA Active not recruiting

120 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplastic Cells, Circulating

NCT05247164 2026-01-15

EUPhORIC

Phase NA Active not recruiting

70 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06917781 2025-11-18

TAYLOR

Phase NA Recruiting

80 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT03960021 2025-10-24

ARFIM

Phase NA Completed

20 enrolled 2 charts

Gastrointestinal

Colonic Neoplasms, Neoplastic Cells, Circulating, Neoplasms

NCT07194616 2025-09-26

Rectal Cancer CTC Trial

Phase NA Recruiting

120 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Rectal Neoplasms

NCT02958852 2025-09-10

ABC-SE

Phase 2 Completed

126 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating

NCT06904625 2025-08-19

CAPT CTC

Phase NA Recruiting

36 enrolled

BreastGenitourinary

Breast Neoplasms, Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT05133154 2025-07-11

GLIOLIPSY

Phase NA Recruiting

50 enrolled

CNS

Glioma, Neoplastic Cells, Circulating

NCT04581109 2025-07-10

EPIDROP

Phase NA Recruiting

100 enrolled

Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

NCT05346536 2025-07-10

CTC-AXL-PANC

Phase NA Recruiting

63 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Clinical Trials

GALIA

BIOLIMEN-1

CTC-Pancreas

CTCNeoBC-E

SLEEP_CTC

OPTIMAL

EUPhORIC

TAYLOR

ARFIM

Rectal Cancer CTC Trial

ABC-SE

CAPT CTC

GLIOLIPSY

EPIDROP

CTC-AXL-PANC

Biomarkers to Detect Endocrine Therapy Resistance